| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/21/2002 | CN1364898A Process for preparing target ribonuclease for curing hepatitis B virus infection |
| 08/21/2002 | CN1364897A New polypeptide-carboxylesterase 19.36 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364896A New polypeptide-phosphatase 15.84 containing tetra polypeptide duplicon structural domain and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364895A New polypeptide-5-phosphatase 12.76 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364894A New polypeptide-human dihydropyrimidinase relative protein 1-101, 20 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364893A New polypeptide-human ubiquitin C end hydrolase 12.65 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364892A New polypeptide-human RNA unwinding enzyme 32.34 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364891A New polypeptide-human serine/threonine protein kinase 13.09 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364890A New polypeptide-human receptor tyrosine kinase 15.62 and polynuceotide for encoding such polypeptide |
| 08/21/2002 | CN1364889A New polypeptide-human periodical protein dependent kinase 16.82 and polynuceotide for encoding such polypeptide |
| 08/21/2002 | CN1364888A New polypeptide-human uracil phosphoribosyl transferase 9.35 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364887A New polypeptide-human alpha 2,3-sialyl-transferase 17.49 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364886A New polypeptide-reduced coenzyme dehydrogenase I dehydrogenase 13.09 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364885A New polypeptide-human 6-acetone acyl tetrahydrogen (bio) pterin synthase (PTPS) 48.18 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364883A New polypeptide-human 6-acetone acyl tetrahydrogen (bio) pterin synthase (PTPS) 11.88 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364882A New polypeptide-human glucoprotein glucosyl transport enzyme 10.01 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364881A New polypeptide-human ribonucleic acid polymerase II7 subunit 26.73 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364879A New polypeptide-human seryl-tRNA synthetase 14.52 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364878A New polypeptide-human chromosome arginine transport ATP enzyme 45.98 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364877A New polypeptide-glyceraldehyde-3-phosphate dehydrogenase 9.57 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364876A New polypeptide-DNA polymerase 9.68 and polynucleotide for encoding such polyupeptide |
| 08/21/2002 | CN1364875A New polypeptide-phosphoribosyl glycinamide synthetase 10.34 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1364812A Human glial cell derived neurotrophic factor and its derivatives and use |
| 08/21/2002 | CN1364803A New polypeptide-human CD63 antigen 56.87 and polynucleotide for encoding such polypeptide |
| 08/21/2002 | CN1089344C Inhibitor of stem cell proliferation and uses thereof |
| 08/21/2002 | CN1089250C Anti-cancer oral liquid contg. lipolytic enzyme |
| 08/21/2002 | CN1089249C Biocompactible somatotropin solutions |
| 08/21/2002 | CN1089248C Medicine for curing diseases in nerve system and its preparing method |
| 08/21/2002 | CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages |
| 08/20/2002 | US6437121 Cationic lipids |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6437098 Genetic engineering; anticarcinogenic agents; side effect reduction |
| 08/20/2002 | US6437094 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 08/20/2002 | US6437093 Methods of treatment comprising administration of Substance P |
| 08/20/2002 | US6437092 Administering polypeptide with lysine residue derivatized with maleimidopropionic acid; analgesics; narcotic abuse withdrawal |
| 08/20/2002 | US6437018 Malleable paste with high molecular weight buffered carrier for filling bone defects |
| 08/20/2002 | US6436996 Administering exogenous sources to cells having apolipoprotein alleles, for prophylaxis of alzheimer's disease |
| 08/20/2002 | US6436980 Transport protein suppressors; microbiocides |
| 08/20/2002 | US6436970 Compositions for the treatment of ARDS or IRDS containing 3-(cycloproplymethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamide and lung surfactant |
| 08/20/2002 | US6436969 Dialysis solutions and methods |
| 08/20/2002 | US6436909 Antisense inhibition of transforming growth factor-β expression |
| 08/20/2002 | US6436908 Administering to cardiac muscle of mammal via cardiac perfusion expression vector comprising promoter active in myocardium operably linked to dna sequence encoding beta adrenergic receptor kinase 1 inhibitor |
| 08/20/2002 | US6436907 Adenovirus-medicated gene transfer to cardiac and vascular smooth muscle |
| 08/20/2002 | US6436904 Treatment of inflammatory diseases in mammals |
| 08/20/2002 | US6436903 Immunomodulating compounds comprising d-isomers of amino acids |
| 08/20/2002 | US6436902 Therapeutic preparations for inhalation |
| 08/20/2002 | US6436901 Composition comprising hirudin, potassium phosphate and sugar, prepared by forming isotonic solution of hirudin, dipotassium hydrogen phosphate, and selected sugar at specified hirudin concentration and freeze drying solution |
| 08/20/2002 | US6436900 Methods of treating a pathology or a fibrotic condition by administering decorin |
| 08/20/2002 | US6436899 Nutritional intervention composition for enhancing and extending satiety |
| 08/20/2002 | US6436897 Pharmaceutical formulations for IGF/IGFBP |
| 08/20/2002 | US6436706 Antisense inhibitor of RECQL4 expression |
| 08/20/2002 | US6436703 Polynucleotide; genetic engineering and gene expression; cloning, molecular hybridization; medical diagnosis |
| 08/20/2002 | US6436700 Anti-sense p21 k-ras |
| 08/20/2002 | US6436692 Isolated nucleic acid molecule encoding 3-hydroxy-3-methylglutaryl coenzyme a synthase, consisting of selected nucleotide sequence |
| 08/20/2002 | US6436691 Chemical compounds |
| 08/20/2002 | US6436684 Isolated nucleic acid molecule consisting of selected nucleotide sequence encoding phenol sulfotransferase protein |
| 08/20/2002 | US6436683 Isolated polypeptide comprising selected amino acid sequence having nucleic acid methylase activity |
| 08/20/2002 | US6436682 Isolated substantially purified gaussia, renilla mulleri or pleuromamma luciferase protein encoded by specified nucleotide sequences |
| 08/20/2002 | US6436673 Isolated polynucleotide encoding neuronal-activity regulated pentraxin, narp, polypeptide having specified amino acid sequence |
| 08/20/2002 | US6436670 Gene and uses therefor |
| 08/20/2002 | US6436669 Isolated nucleic acid molecule comprising polynucleotide having specified nucleotide sequence or sequence encoding specified amino acid sequence |
| 08/20/2002 | US6436667 Isolated polynucleotide, or complement thereof, comprising specified polynucleotide sequence, which encodes polypeptide which promotes development of pancreatic beta cells |
| 08/20/2002 | US6436654 Coactivation of transcription with src-1 and tif2; gene expression |
| 08/20/2002 | US6436652 Method of detecting a pathogen using a virus |
| 08/20/2002 | US6436644 Enzymatic nucleic acid cleaves rna; inflammation and autoimmune disease treatment; medical diagnosis |
| 08/20/2002 | US6436639 Bak promoter expression system |
| 08/20/2002 | US6436637 Polynucleotide; expression vector; antiinflammatory agents; cell proliferative and apoptosis disorder treatment |
| 08/20/2002 | US6436634 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 08/20/2002 | US6436629 Modulating angiogenesis |
| 08/20/2002 | US6436435 Liposome formulation of 5 β steroids |
| 08/20/2002 | US6436430 Self-emulsifying compositions for drugs poorly soluble in water |
| 08/20/2002 | US6436411 Cancer treatment method |
| 08/20/2002 | US6436409 Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 08/20/2002 | US6436407 E. coli heat-labile enterotoxin which has lost its toxicity but has retained its immunologic activity |
| 08/20/2002 | US6436404 Antitumor |
| 08/20/2002 | US6436403 Pharmaceutical composition of the intercellular adhesion molecule ICAM-1 for use in anti-viral prophylactic therapy |
| 08/20/2002 | US6436400 Protease-activated receptor PAR4 ZCHEMR2 |
| 08/20/2002 | US6436397 Reducing autodegradation during processing and purification. lyophilized solutioni with bulking agent, sucrose, trehalose, or raffinose |
| 08/20/2002 | US6436396 Polypeptides having L-asparaginase activity |
| 08/20/2002 | US6436393 Adenoviral vector encoding anti-apoptotic Bcl-2 gene and uses thereof |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | US6436388 Method of treating rhabdomyolysis by administering hepatocyte growth factor |
| 08/20/2002 | US6436387 Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins |
| 08/20/2002 | US6436366 Detecton, treatment and monitoring the patient with poor wound healing ability due to diabetes based on measurement of the breakdown product of nitric oxide (no) in specimens taken from the patient under controlled conditions |
| 08/20/2002 | US6435873 Medication delivery devices |
| 08/20/2002 | CA2250263C Human netrin-1 |
| 08/20/2002 | CA2225530C A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 08/20/2002 | CA2216129C Lactam-containing hydroxamic acids |
| 08/20/2002 | CA2210353C Stabilized external guide sequences |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/2002 | CA2145664C Oligonucleotides having a conserved g4 core sequence |
| 08/20/2002 | CA2111340C Novel polypeptides and their use |
| 08/20/2002 | CA2110055C T cell receptor peptides as therapeutics for immune-related disease |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/20/2002 | CA2063886C Polyethylene protein conjugates |
| 08/20/2002 | CA2059124C Platelet aggregation inhibitors |
| 08/20/2002 | CA2046485C An agent for tyrosinase inhibition |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/19/2002 | CA2372606A1 Compound containing vitamin c prepared during application, use of enzymes to form vitamin c for topical use and cosmetic treatment procedure |